Among the patients with IBS, 27 (45.8%) were using EPO and 34 (57.6%) were using antiphosphate drugs, while 32 (54.2%) were not using EPO and 25 (42.4%) were not using antiphosphate drugs. This evidence concerns the gene EPO and irritable bowel syndrome.